Postintroduction Study of Cost-Effectiveness of Pneumococcal Vaccine PCV10 from Public Sector Payer’s Perspective in the State of Santa Catarina, Brazil
ConclusionsThe vaccine was very cost-effective according to the World Health Organization criterion.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research
More News: Brazil Health | Children | Computers | Disability | International Medicine & Public Health | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Study | Vaccines | Websites | WHO